1.Autologous bone marrow stem cell transplantation for treating myocardial infarction in 6 cases A 4 years follow-up
Shuixiang YANG ; Jing XU ; Guiyu XU ; Haojie DAI ; Jiahe TIAN
Chinese Journal of Tissue Engineering Research 2009;13(10):1969-1972
Six patients with ST segment elevated acute myocardial infarction (AMI), who were 52.5 years old in average, were enrolled and performed the treatment at Tongren Hospital from November 2003 to June 2004. Following percutanecus transluminal coronary angioplasty and stent revascularization, autologous bone marrow stem cell (BMSC) transplantation was performed after informed consent was obtained. Patients were subcutaneously injected with granulocyte colony-stimulating factor (G-CSF) at 1 week before transplantation. When CD34+ cells going up to 1%-3% in peripheral blood, mononuclear cells in peripheral blood were harvested,purified, and further infused into the infarcted related coronary artery with an over-the-wire balloon catheter. Following up was performed every half a year. Four years later, the infarcted area of these patients was further decreased by 8.03%, in the basic descent of 42.7% at 3 months averagely; total infracted area descent was 50.73%, but ejection fraction increased by 4.6% from 50.8%. There was no serious coronary artery restenosis and/or stenosis formation which need revascularization upon angiography.
2.Comparison of 64-slice spiral CTA and MPI in detection of functionally relevant coronary artery lesions
Wei DONG ; Bentao YANG ; Le SONG ; Quan LI ; Jing LI ; Zhenchang WANG ; Haojie DAI
Chinese Journal of Medical Imaging Technology 2009;25(10):1888-1891
Objective To compare the accuracy of 64-slice spiral coronary angiography (CTA) and myocardial perfusion imaging (MPI) in the detection of functionally relevant coronary artery disease (CAD). Methods Twenty patients diagnosed as CAD and 11 suspected CAD were studied. Both 64-slice spiral CTA and MPI images were analyzed. For the evaluation of CTA,luminal narrowing ≥50% and <50% were visually assessed. Perfusion defects on MPI were detected and allocated to their corresponding coronary vessels.Results Among total 124 coronary vessels, CTA detected stenoses ≥50% in 23 arteries, and 7 showed perfusion defects in the corresponding myocardial areas on MPI. Ten of 101 vessels had stenoses<50%,and no perfusion defects in the corresponding myocardial areas was found on MPI. There was difference between the degree of coronary artery stenoses and the risk probabilities of myocardial ischemia (χ~2=6.667, P=0.01). No statistical difference was detected between the coronary artery stenoses site and the risk probabilities of myocardial ischemia (χ~2=6.839, P=0.065). The sensitivity, specificity, negative and positive predictive values of 64-slice spiral CTA in detecting perfusion defects on MPI was 41.18%, 85.05%, 90.01% and 30.43%, respectively.Conclusion 64-slice spiral CTA can display important morphologic information of coronary arteries, but with a low positive predictive value. MPI can be used as an important method to evaluate the change of heart function resulted from CAD.
3.Protease activated receptor-1 targeted 99Tcm-(HYNIC-BMS-200261) (tricine) (TPPTS) imaging on nude mice bearing human breast cancer
Jie LIU ; Xiaojian LIU ; Honglei LI ; Chaoling JIN ; Meng WANG ; Wei FANG ; Haojie DAI ; Jue YAN ; Yumin ZHENG
Chinese Journal of Nuclear Medicine and Molecular Imaging 2018;38(3):195-198
Objective To study the reliability of 99Tcm-(hydrazinonicotinamide (HYNIC)-BMS-200261) (tricine) (trisodium triphenylphosphine-3,3',3"-trisulfonate (TPPTS)) as a radiotracer for protease activated receptor-1 (PAR-1) expression in breast cancer.Methods Fifteen nude mice bearing MDA-MB-435,MDA-MB-231 and MCF-7 human breast cancer xenografts (5 mice for each cell line) with different PAR-1 expression were used for 99Tcm-(HYNIC-BMS-200261) (tricine) (TPPTS) γ imaging,and tumor/non-tumor (T/NT) ratios were obtained with region of interest (ROI) technique.Afterwards,the biodistribution of 99Tcm-(HYNIC-BMS-200261) (tricine) (TPPTS) was analyzed in tumor-bearing nude mice,and the radioactivity in tumor (percentage activity of injection dose per gram of tissue,%ID/g) was calculated.The immunostaining was performed to examine PAR-1 expression in tumor tissue and semi-quantitative analysis was used.One-way analysis of variance and Pearson correlation analysis were used to analyze data.Results At 2 h postinjection,the T/NT ratios were 3.03±0.32,2.27±0.25 and 1.51±0.13 respectively in nude mice bearing MDA-MB-435,MDA-MB-231 and MCF-7 xenografts;the tumor uptakes of 99Tcm-(HYNIC-BMS-200261)(tricine)(TPPTS) were (1.03±0.15),(0.56±0.14) and (0.30±0.06) %ID/g;PAR-1 expression levels were (17.22±2.71) %,(10.78± 1.95) % and (2.80± 1.18) %,respectively (F values:47.66,46.36,62.35,all P<0.05).The T/NT ratios and tumor uptake of 99Tcm-(HYNIC-BMS-200261) (tricine) (TPPTS) at 2 h post-injection were correlated with PAR-1 expression (r values:0.934 and 0.929,both P<0.05).Conclusions 99Tcm-(HYNIC-BMS-200261) (tricine) (TPPTS) imaging could be a noninvasive and effective method for monitoring PAR-1 expression in human breast cancer.
4.Three dimensional collagen scaffolds promote iPSC induction with higher pluripotency.
Qi GU ; He ZHU ; Lei CHEN ; Ling SHUAI ; Jinhui FANG ; Jun WU ; Lei LIU ; Wei LI ; Jianwu DAI ; Jie HAO ; Qi ZHOU
Protein & Cell 2016;7(11):844-848
5.Interpretation of updated NCCN clinical practice guidelines for lung cancer screening (version 2. 2022)
Haojie SI ; Long XU ; Fang WANG ; Hang SU ; Yunlang SHE ; Chenyang DAI ; Xuefei HU ; Deping ZHAO ; Yuming ZHU ; Peng ZHANG ; Gening JIANG ; Chang CHEN
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2022;29(11):1407-1413
Lung cancer is the most common cancer and the leading cause of cancer-related death in China. Early screening of lung cancer proves to be effective in improving its prognosis. The National Comprehensive Cancer Network (NCCN) has updated and released version 2, 2022 NCCN clinical practice guidelines for lung cancer screening in July, 2022. Based on high-quality clinical evidence and the latest research progress, the guidelines have developed and updated criteria for lung cancer screening which have been widely recognized by clinicians around the world. Compared with Chinese lung cancer screening guidelines, this article will interpret the updated content of the brand new 2022 NCCN screening guidelines, providing some reference for the current lung cancer screening practice in our country.